Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Capricor Therapeutics Inc · PHARMACEUTICAL PREPARATIONS · Now $28.53
+5.6% in 3d after detection
Post-detection moves
1h
—
1d
-3.9%
3d
+5.6%
7d
+3.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS